Quality measures

The AAD is working to expand the number and type of dermatology-specific measures available to dermatologists. Dermatology measures are needed to meet the reporting requirements for Centers for Medicare and Medicaid Services' (CMS) Physician Quality Reporting System (PQRS), which has transitioned to the Quality Payment Program in 2017. Measures are also needed for quality improvement efforts, particularly for the AAD’s dermatology clinical database registry DataDermTM.

Measure development process
AAD measure development is led by the physicians on the Performance Measurement Committee (PMC). The PMC employs an evidence-based methodology to support measures with clinical practice guidelines, appropriate use criteria, and other evidence, such as data showing gaps in clinical care or the overuse of medical procedures or therapies. To determine priorities, the PMC periodically conducts a needs assessment and then develops measures with staff support. Measures then undergo peer review by AAD committees, councils, and finally, the Board of Directors. 

After approval, the measures are pilot tested with dermatology practices to determine validity, reliability, and feasibility. Measures are refined based on the results of testing and published. 

Dermatology quality measures for MIPS

The Academy provides support with measure reporting to MIPS through the Academy’s DataDerm clinical registry. Through DataDerm, users can choose from dermatology-specific or dermatology-applicable measures to report for 2017 MIPS. CMS published the 2017 dermatology specialty measure set for MIPS. Find the dermatology specialty set measures that best fit your practice.

View MIPS derm set measures

View 2017 quality measures.